Latest News

Panacea signs agreement with UNICEF, receives USFDA’s approval for migraine drug

Panacea Biotec has signed an agreement with UNICEF to supply Pentavalent Vaccine (Easyfive-TT) in the current year.

It has also got a notification from Pan American Health Organisation (PAHO) to purchase Easyfive-TT vaccine in the event the agency should have any requirements through December 31, 2019.

Panacea Biotec has said in a statement “Total value of this expected business from UN Agencies is worth USD 20.475 million equivalent to around Rs 140 crore based on current exchange rate.”

Read EquityPandit’s Technical Analysis on Nifty Pharma

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



πŸ“°
News
πŸ“ˆ
Prediction
πŸ“Š
FII / DII
πŸ‘”
Advisory
Get 1-2 Index Option Trades Daily